The genetics of bipolar disorder

FJA Gordovez, FJ McMahon - Molecular psychiatry, 2020 - nature.com
Bipolar disorder (BD) is one of the most heritable mental illnesses, but the elucidation of its
genetic basis has proven to be a very challenging endeavor. Genome-Wide Association …

Review and consensus on pharmacogenomic testing in psychiatry

CA Bousman, SA Bengesser, KJ Aitchison… - …, 2021 - thieme-connect.com
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part
due to divergent perceptions of the quality and completeness of the evidence base and …

The organization of the stress system and its dysregulation in depressive illness

PW Gold - Molecular psychiatry, 2015 - nature.com
Stressors are imminent or perceived challenges to homeostasis. The stress response is an
innate, stereotypic, adaptive response to stressors that has evolved in the service of …

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

L Hou, U Heilbronner, F Degenhardt, M Adli… - The Lancet, 2016 - thelancet.com
Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However …

The elements of life and medicines

P Chellan, PJ Sadler - Philosophical Transactions of the …, 2015 - royalsocietypublishing.org
Which elements are essential for human life? Here we make an element-by-element journey
through the periodic table and attempt to assess whether elements are essential or not, and …

Lithium: a review of pharmacology, clinical uses, and toxicity

R Oruch, MA Elderbi, HA Khattab, IF Pryme… - European journal of …, 2014 - Elsevier
A radical drug treatment for bipolar affective disorder (BD) is currently unavailable. This is
attributed to the fact that the precise pathophysiology of this ailment is unclear though a …

Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics

M Alda - Molecular psychiatry, 2015 - nature.com
After decades of research, the mechanism of action of lithium in preventing recurrences of
bipolar disorder remains only partially understood. Lithium research is complicated by the …

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

J Davis, M Maes, A Andreazza, JJ McGrath… - Molecular …, 2015 - nature.com
There is currently considerable imprecision in the nosology of biomarkers used in the study
of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology …

Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide …

AT Amare, KO Schubert, L Hou, SR Clark… - JAMA …, 2018 - jamanetwork.com
Importance Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder
(BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30 …

Lithium as a neuroprotective agent for bipolar disorder: an overview

ELM Ochoa - Cellular and molecular neurobiology, 2022 - Springer
Lithium (Li+) is a first option treatment for adult acute episodes of Bipolar Disorder (BD) and
for the prophylaxis of new depressed or manic episodes. It is also the preferred choice as …